Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis

Both radiolabelled choline and prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) could be used in patients with biochemical recurrent prostate cancer (BRPCa). We aimed to perform a meta-analysis about the head-to-head comparison of detection rate (DR...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Nucl Med Mol Imaging
Main Authors: Treglia, Giorgio, Pereira Mestre, Ricardo, Ferrari, Matteo, Bosetti, Davide G, Pascale, Mariarosa, Oikonomou, Eleni, De Dosso, Sara, Jermini, Fernando, Prior, John O, Roggero, Enrico, Giovanella, Luca
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6526363/
https://ncbi.nlm.nih.gov/pubmed/31139496
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares